The activin receptor ligand trap <scp>ActRIIB</scp> : <scp>ALK4‐Fc</scp> ameliorates cardiomyopathy induced by neuromuscular disease and diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The activin receptor ligand trap ActRIIB : ALK4‐Fc ameliorates cardiomyopathy induced by neuromuscular disease and diabetes

Published:2022-08-29 Issue:24 Volume:596 Page:3145-3158
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Letters

Author:

Li Jia¹,Fredericks Maureen¹,Tang Mingxin¹,Cannell Marishka¹,Joshi Sachindra¹,Kumar Ravindra¹,Andre Patrick¹,Suragani Rajasekhar N. V. S.¹^ORCID

Affiliation:

1. Discovery Group Acceleron Pharma Inc., a subsidiary of Merck & Co., Inc. Rahway NJ USA

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.14464

Reference52 articles.

1. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology

2. Cardiomyopathies

3. Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP